DUBLIN, Jan. 10, 2024 /PRNewswire/ -- The "Global Cord Blood & Tissue Banking Industry Report - Market Size, Segmentation, & Forecasts, 2024" report has been added to ResearchAndMarkets.com's offering.

Industry Analysis Unveils Consolidation Dynamics and Regional Market Expansion

The global cord blood and tissue banking industry is undergoing a period of significant transformation characterized by robust merger and acquisition activities, technological innovation, and market expansion.

A new research publication delves into the intricacies of this dynamic market, offering in-depth insights into current trends, future projections, and strategic developments through 2030.

Amidst the spotlight on the healthcare sector for tailored and advanced therapeutic solutions, cord blood and tissue banking has emerged as a pivotal component. Cord blood, known for its potent hematopoietic stem cells, has a track record of over 40,000 transplants worldwide, heralding a new era in treatment options for a myriad of diseases.

This comprehensive analysis not only highlights the milestones achieved in cord blood and tissue transplants but also sheds light on the storage capabilities of both public and private banks worldwide.

Strategic Developments and Market Segmentation

• Public and private cord blood banks' cryopreservation units
• Global utilization of cord blood cells in regenerative medicine
• Emerging technologies enhancing public banks' financial sustainability
• Expansion services in the realm of cord blood banking

Highlighting the geographical market expanse, the report underscores India's and China's dominant positions, collectively housing over a third of the world's population. Such demographics present vast opportunities for cord blood and tissue banking services. LifeCell International's commanding presence in India, managing over 320,000 stem cell units, exemplifies the regional market's potential.

The U.S landscape has not been left behind in the wave of industry consolidation, with major players like CooperSurgical and Cryoholdco cementing their status through strategic acquisitions. With a focus on enhancing comprehensive cord blood banking services, the industry is witnessing expanded offerings that include reproductive services, genetic testing, and cell therapy product development.

Furthermore, the report identifies the burgeoning market segments within the cord blood and tissue banking sphere, from storage market revenues and the therapeutic use of cord blood in transplantation medicine to the cutting-edge arena of regenerative medicine applications.

Celebrating Scientific Progress and Market Evolution

In a market ripe with scientific innovation, such as the groundbreaking FDA approval of Omisirge for recuperating cancer patients' white blood cells, the industry's potential is unmistakable. Moreover, the diverse application in clinical trials, with over 1,200 studies, illustrates the industry's pivotal role in advancing healthcare.

The strategic report is an indispensable resource for stakeholders looking to navigate the complexities of the cord blood and tissue banking industry. It stands as a testament to the ongoing metamorphosis of this niche yet essential healthcare service, offering a horizon of opportunities for market participants and recipients alike.

Advocating for informed decision-making and strategic positioning within the healthcare sector, this publication is an authoritative guide that equips entities with the knowledge to leverage the unfolding trends and optimize their operational footprint in the cord blood and tissue banking markets.

As the industry continues to evolve, the insights from this report pave the way for informed dialogue, strategic planning, and competitive positioning within the global cord blood and tissue banking landscape.

The report presents findings on the following topics:

• Number of cord blood and tissue units cryopreserved in public and private cord blood banks worldwide
• Number of hematopoietic stem cell transplants (HSCTs) performed globally using cord blood cells
• Utilization of cord blood cells in regenerative medicine clinical trials
• The decline of the utilization of cord blood cells in HSCT since 2005
• Emerging technologies that will influence the financial sustainability of public cord blood banks
• The future scope for companion products derived from cord blood
• The changing landscape of the cord blood and tissue banking market
• Expansion and extension of services by cord blood banks
• Types of cord blood banks
• Economic model of public cord blood banks
• Cost analysis for public cord blood banks
• Economic model of private cord blood banks
• Cost analysis for private cord blood banks
• Profit margins for private cord blood banks
• Pricing for processing and storage in private banks
• Rate per cord blood unit in the U.S. and Europe
• Indications for the use of cord blood-derived HSCs within transplantation medicine
• Diseases targeted by cord blood-derived MSCs in regenerative medicine
• Cord blood processing technologies
• Number of clinical trials, number of published scientific papers, and amount of NIH funding for cord blood research
• Number and types of patents for cord blood, cord tissue, and placental products
• Transplantation data from different cord blood registries

Companies Mentioned

• AllCells
• AlphaCord
• Americord Registry, Inc.
• Angiocrine Bioscience
• Anja Health Personalized Cord Blood Banking
• Anthony Nolan
• Baylx, Inc.
• Be The Match
• Biocell Center
• BioEden
• BioIntegrate, LLC
• Bloodworks Northwest
• California Umbilical Cord Collection Program
• Carolinas Cord Blood Bank (CCBB)
• Celaid Therapeutics
• Celebration Stem Cell Centre (CSCC)
• Cell Care
• Cellenkos, Inc.
• Cells4Life Group LLP
• CellSave Arabia
• Celularity, Inc.
• Center for International Blood and Marrow Transplant Research (CIBMTR)
• CHOC Blood Bank
• Cleveland Cord Blood Center
• ClinImmune Cell and Gene Therapy
• CooperSurgical
• Cord Blood Bank of Arkansas (CBBA)
• Cord Blood Center Group
• Cord Blood Registry (owned by CooperSurgical)
• Cord for Life
• CordLife Group, Ltd.
• CordVida
• Crioestaminal
• Cryo-Cell International, Inc.
• CryoCyte, LLC
• Cryoholdco
• Cryolife
• Cryopoint
• Cryoviva Biotech Pvt., Ltd.
• DentCell
• DKMS gGMBH
• Duke University School of Medicine
• European Society for Blood and Bone Marrow Transplantation (EBMT)
• Ever Supreme Bio Technology, Co., Ltd.
• ExCellThera
• FamiCord Group
• Fate Therapeutics, Inc.
• Future Health
• Gamida Cell
• GeneCell
• Global Cord Blood Corporation (GCBC)
• Glycostem Therapeutics
• Hawaii Cord Blood Bank
• HealthBaby
• HealthBanks Biotech Company Ltd.
• HealthBanksUSA
• HEMAFUND
• Hemogenyx Pharmaceuticals
• IMMUNIQUE
• Insception LifeBank
• JP McCarthy Cord Stem Cell Bank
• Kangstem Biotech, Co., Ltd.
• Life Line Stem Cell
• LifebankUSA
• LifeCell International Pvt. Ltd.
• LifeSouth Cord Blood Bank
• Magenta Therapeutics
• Maze Cord Blood
• MD Anderson Cord Blood Bank
• Medipost, Co., Ltd.
• Mesoblast, Ltd.
• MiracleCord, Inc.
• Mononuclear Therapeutics, Ltd.
• New England Cord Blood Bank, Inc.
• New York Blood Center
• OrganaBio
• PacifiCord
• PBKM FamiCord
• Plasticell Ltd.
• ReeLabs Pvt. Ltd.
• Restem, LLC
• San Diego Cord Blood Bank
• Saneron CCEL Therapeutics, Inc.
• Sanpower Group
• SmartCells
• SSM Cardinal Glennon Children's Medical Center
• Stem Cell Cryobank, Inc.
• Stembanc, Inc.
• StemCyte, Inc.
• Throne Biotechnologies, Inc.
• Transcell Biolife
• Upstate Cord Blood Bank
• VCANBIO Cell & Gene Engineering Corporation
• Versity, Inc.
• ViaCord
• Vita 34 AG
• Vitalant Clinical Services
• World Marrow Donor Association (WMDA)
• Worldwide Network for Blood & Marrow Transplantation (WBMT)

For more information about this report visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo:

SOURCE Research and Markets